Rhaponticin decreases the metastatic and angiogenic abilities of cancer cells via suppression of the HIF‑1α pathway

Aeyung Kim(Korea Institute of Oriental Medicine), Jin Yeul(Jianghan University)
International Journal of Oncology
July 11, 2018
Cited by 36


Related Papers